Kits Eyecare Ltd.
KTYCF
$9.76
$0.050.53%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.90% | 1.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.90% | 1.62% | |||
| Cost of Revenue | -2.90% | 1.10% | |||
| Gross Profit | 25.15% | 2.61% | |||
| SG&A Expenses | 22.66% | 3.19% | |||
| Depreciation & Amortization | 16.87% | -30.75% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.30% | 1.61% | |||
| Operating Income | 44.20% | 1.87% | |||
| Income Before Tax | 398.19% | -77.73% | |||
| Income Tax Expenses | 196.83% | -53.30% | |||
| Earnings from Continuing Operations | 649.84% | -86.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 649.84% | -86.53% | |||
| EBIT | 44.20% | 1.87% | |||
| EBITDA | 36.13% | -10.04% | |||
| EPS Basic | 615.25% | -86.53% | |||
| Normalized Basic EPS | 64.17% | -35.48% | |||
| EPS Diluted | 615.25% | -86.47% | |||
| Normalized Diluted EPS | 70.31% | -34.57% | |||
| Average Basic Shares Outstanding | 4.62% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.73% | -1.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||